September 2026
The global in vivo CAR-T therapy market size was evaluated at USD 861.25 million in 2026 and is predicted to hit around USD 10,841.07 million by 2035, growing at a CAGR of 32.50%.
September 2026
The home infusion therapy market size was valued at USD 45.23 billion in 2026 and is projected to hit around USD 90.65 billion by 2035 with a CAGR of 8.04%.
September 2026
The global in vivo cell reprogramming market is expanding as regenerative medicine advances toward direct in-body cell conversion for tissue repair and disease treatment.
September 2026
The nicotine replacement therapy market generated USD 108.96 billion in 2026, with prominent nicotine replacement therapy companies including Fertin Pharma, Philip Morris Products S.A., British American Tobacco plc, Glenmark Pharmaceuticals.
September 2026
The global radiotherapy monitoring devices market size is estimated to hit around USD 2.48 billion by 2035 increasing from USD 1.29 billion in 2025, with a CAGR of 6.74%.
September 2026
The global advanced therapy medicinal products market size is projected to hit around USD 192.67 billion by 2035 increasing from USD 49.11 billion in 2026, with a CAGR of 16.44%.
September 2026
The continuous renal replacement therapy market size was USD 1.71 billion in 2026, with leading continuous renal replacement therapy market players including baxter international inc, nikkiso co. ltd, infomed sa, Medtronic plc, bellco.
September 2026
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 18.06 billion in 2026, with a CAGR of 26.62%.
September 2026
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 632.03 million in 2026, with a CAGR of 7.34%.
September 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.83 billion in 2026, with a CAGR of 9.70%.
September 2026
The global in vivo CRO market size is estimated to hit around USD 11.7 billion by 2035, increasing from USD 5.84 billion in 2026, with a CAGR of 8.11%.
September 2026
The global compounding chemotherapy market size was evaluated at USD 7.39 billion in 2026 and is predicted to surge around USD 13.36 billion by 2035, growing at a CAGR of 6.80%.
September 2026
The global intensity modulated radiotherapy market size is estimated to hit around USD 5.10 billion by 2035 increasing from USD 2.89 billion in 2026, with a CAGR of 6.52 %.
September 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 1,127.65 million in 2026, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
September 2026
The U.S. cell therapy manufacturing market was worth USD 1.97 billion in 2026, with key U.S. cell therapy manufacturing market players including Merck KGaA, Thermo Fisher Scientific, Catalent, Inc.
September 2026
The AI in cancer immunotherapy drugs market reached USD 3.52 billion in 2026, featuring leading AI in cancer immunotherapy drugs market companies such as Exscientia, Insilico Medicine.
August 2026
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%
July 2026
The cell and gene therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
July 2026
The oncology combination therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
July 2026
The single dose gene therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
July 2026
The global continuous renal replacement therapy consumables market size was evaluated at USD 920.17 million in 2025 and is predicted to hit around USD 2,069.01 million by 2035, growing at a CAGR of 8.44%.
June 2026
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The global cell therapy manufacturing market size was valued at USD 5.55 billion in 2025 and is projected to hit around USD 21.02 billion by 2035 with a CAGR of 14.24%.
May 2026
The global combination antibody therapy market size is estimated to hit around USD 700.59 billion by 2035 increasing from USD 241.03 billion in 2025, with a CAGR of 11.26%.
February 2026
The global veterinary radiotherapy market size was evaluated at USD 3.59 billion in 2025 and is predicted to hit around USD 7.43 billion by 2035, growing at a CAGR of 7.56%.
December 2025
The global automated and closed cell therapy processing system market size is expected to hit around USD 14.46 billion by 2035 with a CAGR of 22.76%.
November 2025
The global alpha-1 antitrypsin deficiency augmentation therapy market size is estimated to hit around USD 2.96 billion by 2034 from USD 1.84 billion in 2026, at a CAGR of 6.14%.
August 2025
The intravenous (IV) hydration therapy market size reached USD 2.71 billion in 2024 and is projected to surpass around USD 5.84 billion by 2034, with a notable CAGR of 7.98%.
July 2025
The global cold pain therapy market size was estimated at USD 2.22 billion in 2024 and is predicted to surpass around USD 3.64 billion by 2034 with a notable CAGR of 5.08%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com